The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune disease.

Autor: Chang, Christina, Chin-San Loo, Xuan Zhao, Solt, Laura A., Yuqiong Liang, Bapat, Sagar P., Han Cho, Kamenecka, Theodore M., Leblanc, Mathias, Atkins, Annette R., Yu, Ruth T., Downes, Michael, Burris, Thomas P., Evans, Ronald M., Ye Zheng
Předmět:
Zdroj: Proceedings of the National Academy of Sciences of the United States of America; 9/10/2019, Vol. 116 Issue 37, p18528-18536, 9p
Abstrakt: T helper 17 (Th17) cells produce interleukin-17 (IL-17) cytokines and drive inflammatory responses in autoimmune diseases such as multiple sclerosis. The differentiation of Th17 cells is dependent on the retinoic acid receptor-related orphan nuclear receptor RORγt. Here, we identify REV-ERBα (encoded by Nr1d1), a member of the nuclear hormone receptor family, as a transcriptional repressor that antagonizes RORγt function in Th17 cells. REV-ERBα binds to ROR response elements (RORE) in Th17 cells and inhibits the expression of RORγt-dependent genes including Il17a and Il17f. Furthermore, elevated REV-ERBα expression or treatment with a synthetic REV-ERB agonist significantly delays the onset and impedes the progression of experimental autoimmune encephalomyelitis (EAE). These results suggest that modulating REV-ERBα activity may be used to manipulate Th17 cells in autoimmune diseases. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index